The North America smart inhalers market is expected to reach US$ 3,749.90 Mn in 2027 from US$ 503.91 Mn in 2018. The market is estimated to grow with a CAGR of 25.7% from 2019-2027.
North America Smart Inhalers Market The growth of the market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.
North America Smart Inhalers Market The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been rise in the number of smokers as well as air pollution in developed as well as developing countries. Asthma is a non-communicable disease categorized by recurrent attacks of breathlessness and wheezing, which differ in severity and frequency from person to person. North America Smart Inhalers Market While an asthma attack occurs, the lining of the bronchial tubes swells, affecting the airways to narrow, hence limiting the flow of air into and out of the lungs. Recurrent asthma symptoms frequently lead to feeling of daytime fatigue, sleeplessness, reduced activity levels and school and work absence. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma are approximately 19 million in the United States, accounting for almost 7.7% of the total adult population.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00006805
Similarly, there has been rising prevalence of COPD across the North America. North America Smart Inhalers Market Chronic obstructive pulmonary disease (COPD) is a progressive fatal lung disease that leads to breathlessness, leading to predisposes then exacerbations and later causes serious illness. As per the Global Burden of Disease Study report, a prevalence of around 251 million cases of COPD were recorded globally during the year 2016. North America Smart Inhalers Market It is estimated that globally approximately 3.17 million deaths were caused due to COPD during the year 2015, accounting for almost 5% of all deaths in 2015. North America Smart Inhalers Market The prevalence of COPD has been high in developed nations during the recent years. For instance, COPD is recognized as the third leading cause of death by disease in the United States. Approximately, 11 million individual are diagnosed with COPD. Hence, the rising prevalence of respiratory conditions such as asthma and COPD is anticipated to fuel the growth of the smart inhalers market across the globe at an exponential rate.
US is expected to lead the market in the North America region because the US has presence of various associations which provide help in the field of lung diseases. For instance, American Lung Association conducts research activities, education and training as well as undertakes initiatives to offer better treatment and support for the patients suffering with respiratory conditions such as asthma, COPD, influenza, lung cancer, pneumonia, and pulmonary fibrosis among others. North America Smart Inhalers Market Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-smart-inhalers-market
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
GlaxoSmithKline plc
Adherium Ltd.
Vectura Group plc
Novartis AG
Findair Sp. z o. o.
Cohero Health
Crux Product Design Ltd
Teva Pharmaceuticals
3M
Amiko Digital Health Limited
North America Smart Inhalers Market
North America Smart Inhalers Market The healthcare landscape is constantly evolving with innovations that improve patient outcomes and provide solutions for complex diseases. One such innovation is the introduction of smart inhalers, which have revolutionized the management of respiratory diseases. These inhalers, equipped with digital technology, have not only improved the way patients manage chronic conditions like asthma and chronic obstructive pulmonary disease (COPD), but they have also helped increase medication adherence, reduce hospitalizations, and enhance overall quality of life for individuals suffering from these diseases. In North America, smart inhalers have become a key part of respiratory care. This article explores the North American smart inhaler market, its drivers, trends, challenges, and the future outlook of the industry.
Similarly, COPD, a group of progressive lung diseases including emphysema and chronic bronchitis, is a major public health concern, especially in older adults and those with a history of smoking. COPD exacerbations can significantly impact the quality of life and lead to frequent hospitalizations, making effective management crucial. COPD has emerged as one of the leading causes of death worldwide, with an estimated 3.23 million deaths in 2019 according to the WHO.
Role of Smart Inhalers in Managing Respiratory Diseases
Smart inhalers are connected devices designed to help patients with asthma and COPD better manage their conditions. These devices feature integrated sensors that track the use of medication, ensuring patients adhere to prescribed treatment regimens. The inhalers are often paired with mobile apps that collect and store data on medication usage, environmental conditions, and symptom triggers. This data is useful for both patients and healthcare providers, allowing for more personalized treatment plans.
The growing geriatric population in North America further drives the market for smart inhalers. Older adults, who often have multiple chronic conditions, may benefit from the real-time monitoring and reminders provided by these devices, reducing the risk of mismanagement and improving overall health outcomes.
Additionally, rising awareness regarding the significance of medication adherence and the role of technology in healthcare has spurred the adoption of smart inhalers. Healthcare providers are increasingly recommending smart inhalers as a tool to enhance patient engagement and improve medication adherence, thus helping to mitigate the challenges posed by conditions like asthma and COPD.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
You can see this
North America Galacto Oligosaccharide Market- https://www.openpr.com/news/3925592/north-america-galacto-oligosaccharide-market-overview-top-key
North America RTD Alcoholic Beverages Market- https://www.openpr.com/news/3926211/north-america-rtd-alcoholic-beverages-market-by-key-players
North America Cancer Tissue Diagnostics Market- https://www.openpr.com/news/3925787/north-america-ceramic-balls-market-key-players-size-trends
